Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Acrocallosal Syndrome Therapeutics MarketThe global Acrocallosal Therapeutics Market is currently valued at USD 147.9 million ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

The rising cost of living continues to hit Nigerian households and the latest example is the price of toothpaste, which is ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.

Genoa Ventures, a venture capital firm investing in science-driven companies of consequence, is proud to announce the ...